• Target

    £1,500,000

  • Type

    Equity

  • Close Date

    Oct 1 2019

  • Status

    Open

RISK WARNING: Your capital is at risk. The risks include: the lack of liquidity in this market in terms of being able to realise investments and the loss of the value of investment. When you invest any loss in value will not be covered by the Financial Services Compensation Scheme.
Please read FULL risk warning.

NoxSudor

Noxsudor will be selling Ospera, a food supplement designed to relieve women from the menopausal symptoms of hot flashes and night sweats.

Logo2

Investment closes only once the total pledged amount passes the minimum of £500,000

Total Pledged: £180,476
Max

£1,500,000

£

A pledge is not a commitment. You will be asked to confirm in the next section.

Track
Contact
Companies
House
Twitter

Overview

Noxsudor Therapeutics Limited acquired an exclusive global license agreement to market and commercialise Ospera from ActiveSignal. Ospera is a food supplement which has been developed to alleviate women from experiencing the menopausal symptoms of hot flushes and night sweats.

Menopause, just like puberty, is a natural life event that all women experience. During this time c.80% of women experiencing menopause tend to suffer from night sweats and hot flashes, and often these symptoms can last between 5 and 10 years. Existing solutions include Hormone Replacement Therapy and herbal remedies, which can be unappealing due to side-effects or ineffectiveness. 

Ospera has been developed from natural ingredients and has proven effective in relieving menopausal women from night sweats and hot flushes. The company has completed the product’s research and development phase and is ready to be commercialised. Noxsudor aspires to become the product of choice for menopausal women in the UK first and then worldwide.  

Ospera design
Deal Manager avatar

Deal Manager
Agne Pakalniskyte

  • Sector: Healthcare
  • Region: UK: London
  • Stage: Pre-revenue, over £200k to £1m invested to date
  • Eligible Tax: EIS
  • Board Requirement: Will consider further board appointments
  • Pre Money Valuation: £2,396,123
  • Share Price: £1.25
  • Originator: Envestors
This section is currently locked.
Please Sign Up or Log In to unlock.

Team

This section is currently locked.
Please Sign Up or Log In to unlock.

Market

This section is currently locked.
Please Sign Up or Log In to unlock.

Investment

This section is currently locked.
Please Sign Up or Log In to unlock.

Discussions

This section is currently locked.
Please Sign Up or Log In to unlock.

Documents

1 documents are currently locked.
To unlock the Public Data Room you will need to Sign Up or Login

Originator


Originator: Envestors

Investment Focus: Equity and Debt

About: Envestors is a FCA regulated corporate finance adviser in the UK and operates an international network of sophisticated investors investing an average of £42,000 in high growth unquoted companies seeking £250,000 to £2m in equity funding.

Contact Name: Oliver Woolley

  • Registered Investors
    Over 1000
  • Investment through platform
    Over £100m